Radioiodine Theranostics: Increasing Dialogue and Collaboration.

S NMMI has been increasing dialogue and collaboration with other societies with similar interests over the last several years. One important area is in diagnosis and management of differentiated thyroid cancer (DTC)— radioiodine theranostics. With the efforts of multiple individuals and committees, we have significantly increased our dialogue with SNMMI members as well as collaboration with other medical societies and organizations in the United States, Europe, and other countries. Active groups within SNMMI include the Therapy Center of Excellence (TCoE), the Committee on Radioiodine Theranostics (CORT), and the Appropriate Use Committee. Following is a status report on our collective efforts in advancing radioiodine theranostics.